{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:03:28Z","timestamp":1792724608195,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11926-020-00950-3","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T16:03:59Z","timestamp":1598630639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact and Management of Dysphagia in Inflammatory Myopathies"],"prefix":"10.1007","volume":"22","author":[{"given":"Rachel","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"950_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JND-180308","volume":"5","author":"J Schmidt","year":"2018","unstructured":"Schmidt J. Current classification and management of inflammatory myopathies. J Neuromuscul Dis. 2018;5:109\u201329. https:\/\/doi.org\/10.3233\/JND-180308.","journal-title":"J Neuromuscul Dis"},{"key":"950_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00455-001-0113-5","volume":"17","author":"O Ekberg","year":"2002","unstructured":"Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P. Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia. 2002;17:139\u201346. https:\/\/doi.org\/10.1007\/s00455-001-0113-5.","journal-title":"Dysphagia."},{"key":"950_CR3","doi-asserted-by":"publisher","unstructured":"\u2022 Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis. 2018;77:30\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211868. This large multicenter cohort analysis included 3067 patients from 11 countries; associations between different myositis subtypes, extramuscular involvement, environmental exposure and medications were assessed.","DOI":"10.1136\/annrheumdis-2017-211868"},{"key":"950_CR4","doi-asserted-by":"publisher","unstructured":"Dobloug C, Garen T, Bitter H, Stj\u00e4rne J, Stenseth G, Gr\u00f8vle L, et al. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis. 2015;74:1551\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2013-205127.","DOI":"10.1136\/annrheumdis-2013-205127"},{"key":"950_CR5","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/acr.20325","volume":"62","author":"I Marie","year":"2010","unstructured":"Marie I, Menard J-F, Hatron PY, Hachulla E, Mouthon L, Tiev K, et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken). 2010;62:1748\u201355. https:\/\/doi.org\/10.1002\/acr.20325.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"950_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4065\/82.4.441","volume":"82","author":"TH Oh","year":"2007","unstructured":"Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc. 2007;82:441\u20137. https:\/\/doi.org\/10.4065\/82.4.441.","journal-title":"Mayo Clin Proc"},{"key":"950_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00455-011-9384-7","volume":"27","author":"PC Langdon","year":"2012","unstructured":"Langdon PC, Mulcahy K, Shepherd KL, Low VH, Mastaglia FL. Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature. Dysphagia. 2012;27:408\u201317. https:\/\/doi.org\/10.1007\/s00455-011-9384-7.","journal-title":"Dysphagia."},{"key":"950_CR8","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00415-009-5229-9","volume":"256","author":"FM Cox","year":"2009","unstructured":"Cox FM, Verschuuren JJ, Verbist BM, Niks EH, Wintzen AR, Badrising UA. Detecting dysphagia in inclusion body myositis. J Neurol. 2009;256:2009\u201313. https:\/\/doi.org\/10.1007\/s00415-009-5229-9.","journal-title":"J Neurol"},{"key":"950_CR9","doi-asserted-by":"publisher","unstructured":"Needham M, James I, Corbett A, Day T, Christiansen F, Phillips B, et al. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry. 2008;79:1056\u201360. https:\/\/doi.org\/10.1136\/jnnp.2007.138891.","DOI":"10.1136\/jnnp.2007.138891"},{"key":"950_CR10","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1007\/s00415-005-0884-y","volume":"252","author":"UA Badrising","year":"2005","unstructured":"Badrising UA, Maat-Schieman MLC, van Houwelingen JC, van Doorn PA, van Duinen SG, van Engelen BGM, et al. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol. 2005;252:1448\u201354. https:\/\/doi.org\/10.1007\/s00415-005-0884-y.","journal-title":"J Neurol"},{"key":"950_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/00005537-199807000-00009","volume":"108","author":"SM Houser","year":"1998","unstructured":"Houser SM, Calabrese LH, Strome M. Dysphagia in patients with inclusion body myositis. Laryngoscope. 1998;108:1001\u20135. https:\/\/doi.org\/10.1097\/00005537-199807000-00009.","journal-title":"Laryngoscope."},{"key":"950_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/brain\/112.3.727","volume":"112","author":"BP Lotz","year":"1989","unstructured":"Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: observations in 40 patients. Brain. 1989;112:727\u201347.","journal-title":"Brain."},{"key":"950_CR13","doi-asserted-by":"publisher","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Mego M, Accarino A, Jubany L, Azpiroz F, et al. High-resolution manometry in patients with idiopathic inflammatory myopathy: elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset. Muscle Nerve. 2017;56:386\u201392. https:\/\/doi.org\/10.1002\/mus.25507.","DOI":"10.1002\/mus.25507"},{"key":"950_CR14","doi-asserted-by":"publisher","unstructured":"Mugii N, Hasegawa M, Matsushita T, Hamaguchi Y, Oohata S, Okita H, et al. Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies. PLoS One. 2016;11:e0154746. https:\/\/doi.org\/10.1371\/journal.pone.0154746.","DOI":"10.1371\/journal.pone.0154746"},{"key":"950_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3346\/jkms.2009.24.4.715","volume":"24","author":"S-J Na","year":"2009","unstructured":"Na S-J, Kim SM, Sunwoo IN, Choi Y-C. Clinical characteristics and outcomes of juvenile and adult dermatomyositis. J Korean Med Sci. 2009;24:715\u201321. https:\/\/doi.org\/10.3346\/jkms.2009.24.4.715.","journal-title":"J Korean Med Sci"},{"key":"950_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/000155502753600894","volume":"82","author":"A Parodi","year":"2002","unstructured":"Parodi A, Caproni M, Marzano AV, de Simone C, La Placa M, Quaglino P, et al. Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies. Acta Derm Venereol. 2002;82:48\u201351. https:\/\/doi.org\/10.1080\/000155502753600894.","journal-title":"Acta Derm Venereol"},{"key":"950_CR17","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1136\/jnnp.51.12.1542","volume":"51","author":"AR Wintzen","year":"1988","unstructured":"Wintzen AR, Bots GT, de Bakker HM, Hulshof JH, Padberg GW. Dysphagia in inclusion body myositis. J Neurol Neurosurg Psychiatry. 1988;51:1542\u20135. https:\/\/doi.org\/10.1136\/jnnp.51.12.1542.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"950_CR18","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1212\/WNL.43.6.1241","volume":"43","author":"DS Riminton","year":"1993","unstructured":"Riminton DS, Chambers ST, Parkin PJ, Pollock M, Donaldson IM. Inclusion body myositis presenting solely as dysphagia. Neurology. 1993;43:1241\u20133. https:\/\/doi.org\/10.1212\/WNL.43.6.1241.","journal-title":"Neurology."},{"key":"950_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/000348949610500501","volume":"105","author":"J Shapiro","year":"1996","unstructured":"Shapiro J, Martin S, DeGirolami U, Goyal R. Inflammatory myopathy causing pharyngeal dysphagia: a new entity. Ann Otol Rhinol Laryngol. 1996;105:331\u20135. https:\/\/doi.org\/10.1177\/000348949610500501.","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"950_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1136\/gut.52.4.471","volume":"52","author":"RB Williams","year":"2003","unstructured":"Williams RB, Grehan MJ, Hersch M, Andre J, Cook IJ. Biomechanics, diagnosis, and treatment outcome in inflammatory myopathy presenting as oropharyngeal dysphagia. Gut. 2003;52:471\u20138. https:\/\/doi.org\/10.1136\/gut.52.4.471.","journal-title":"Gut."},{"key":"950_CR21","doi-asserted-by":"publisher","unstructured":"Shibata S, Izumi R, Hara T, Ohshima R, Nakamura N, Suzuki N, et al. Five-year history of dysphagia as a sole initial symptom in inclusion body myositis. J Neurol Sci. 2017;381:325\u20137. https:\/\/doi.org\/10.1016\/j.jns.2017.09.014.","DOI":"10.1016\/j.jns.2017.09.014"},{"key":"950_CR22","doi-asserted-by":"publisher","unstructured":"Labeit B, Muhle P, Suntrup-Krueger S, Ahring S, Ruck T, Dziewas R, et al. Dysphagia as isolated manifestation of Jo-1 associated myositis? Front Neurol. 2019;10:739. https:\/\/doi.org\/10.3389\/fneur.2019.00739.","DOI":"10.3389\/fneur.2019.00739"},{"key":"950_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jns.2017.07.031","volume":"380","author":"A Schrey","year":"2017","unstructured":"Schrey A, Airas L, Jokela M, Pulkkinen J. Botulinum toxin alleviates dysphagia of patients with inclusion body myositis. J Neurol Sci. 2017;380:142\u20137. https:\/\/doi.org\/10.1016\/j.jns.2017.07.031.","journal-title":"J Neurol Sci"},{"key":"950_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10072-011-0814-y","volume":"33","author":"K-Y Murata","year":"2012","unstructured":"Murata K-Y, Kouda K, Tajima F, Kondo T. A dysphagia study in patients with sporadic inclusion body myositis (s-IBM). Neurol Sci. 2012;33:765\u201370. https:\/\/doi.org\/10.1007\/s10072-011-0814-y.","journal-title":"Neurol Sci"},{"key":"950_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","volume":"83","author":"K Dank\u00f3","year":"2004","unstructured":"Dank\u00f3 K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore). 2004;83:35\u201342. https:\/\/doi.org\/10.1097\/01.md.0000109755.65914.5e.","journal-title":"Medicine (Baltimore)"},{"key":"950_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/art.1780280303","volume":"28","author":"J Benbassat","year":"1985","unstructured":"Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis\/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum. 1985;28:249\u201355. https:\/\/doi.org\/10.1002\/art.1780280303.","journal-title":"Arthritis Rheum"},{"key":"950_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","volume":"14","author":"I Marie","year":"2012","unstructured":"Marie I. Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep. 2012;14:275\u201385. https:\/\/doi.org\/10.1007\/s11926-012-0249-3.","journal-title":"Curr Rheumatol Rep"},{"key":"950_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1196\/annals.1361.047","volume":"1051","author":"A Ponyi","year":"2005","unstructured":"Ponyi A, Constantin T, Garami M, Andr\u00e1s C, T\u00e1llai B, V\u00e1ncsa A, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005;1051:64\u201371. https:\/\/doi.org\/10.1196\/annals.1361.047.","journal-title":"Ann N Y Acad Sci"},{"key":"950_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ncl.2014.04.001","volume":"32","author":"MM Dimachkie","year":"2014","unstructured":"Dimachkie MM, Barohn RJ. Inclusion body myositis. Neurol Clin. 2014;32:629\u201346, vii. https:\/\/doi.org\/10.1016\/j.ncl.2014.04.001.","journal-title":"Neurol Clin"},{"key":"950_CR30","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/BOR.0000000000000116","volume":"26","author":"AH Lahouti","year":"2014","unstructured":"Lahouti AH, Amato AA, Christopher-Stine L. Inclusion body myositis: update. Curr Opin Rheumatol. 2014;26:690\u20136. https:\/\/doi.org\/10.1097\/BOR.0000000000000116.","journal-title":"Curr Opin Rheumatol"},{"key":"950_CR31","doi-asserted-by":"publisher","unstructured":"Price MA, Barghout V, Benveniste O, Christopher-Stine L, Corbett A, de Visser M, et al. Mortality and causes of death in patients with sporadic inclusion body myositis: survey study based on the clinical experience of specialists in Australia, Europe and the USA. J Neuromuscul Dis. 2016;3:67\u201375. https:\/\/doi.org\/10.3233\/JND-150138.","DOI":"10.3233\/JND-150138"},{"key":"950_CR32","doi-asserted-by":"publisher","unstructured":"Benveniste O, Guiguet M, Freebody J, Dubourg O, Squier W, Maisonobe T, et al. Long-term observational study of sporadic inclusion body myositis. Brain. 2011;134:3176\u201384. https:\/\/doi.org\/10.1093\/brain\/awr213.","DOI":"10.1093\/brain\/awr213"},{"key":"950_CR33","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1093\/brain\/awr217","volume":"134","author":"FM Cox","year":"2011","unstructured":"Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJGM, Badrising UA. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain. 2011;134:3167\u201375. https:\/\/doi.org\/10.1093\/brain\/awr217.","journal-title":"Brain."},{"key":"950_CR34","doi-asserted-by":"publisher","unstructured":"\u2022 Taira K, Yamamoto T, Mori-Yoshimura M, Fujita S, Oya Y, Nishino I, et al. Obstruction-related dysphagia in inclusion body myositis: cricopharyngeal bar on videofluoroscopy indicates risk of aspiration. J Neurol Sci. 2020;413:116764. https:\/\/doi.org\/10.1016\/j.jns.2020.116764. This study analyzed the predictive risk factors for aspiration pneumonia in patients with inclusion body myositis; one of these factors was the presence of a cricopharyngeal bar (CB) on videofluoroscopic examination.","DOI":"10.1016\/j.jns.2020.116764"},{"key":"950_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00455-011-9338-0","volume":"27","author":"KP Mulcahy","year":"2012","unstructured":"Mulcahy KP, Langdon PC, Mastaglia F. Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence. Dysphagia. 2012;27:64\u20139. https:\/\/doi.org\/10.1007\/s00455-011-9338-0.","journal-title":"Dysphagia."},{"key":"950_CR36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0016-5085(00)70137-5","volume":"118","author":"KL Wallace","year":"2000","unstructured":"Wallace KL, Middleton S, Cook IJ. Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia. Gastroenterology. 2000;118:678\u201387.","journal-title":"Gastroenterology."},{"key":"950_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1460-6984.2012.00197.x","volume":"48","author":"SK Archer","year":"2013","unstructured":"Archer SK, Garrod R, Hart N, Miller S. Dysphagia in Duchenne muscular dystrophy assessed by validated questionnaire. Int J Lang Commun Disord. 2013;48:240\u20136. https:\/\/doi.org\/10.1111\/j.1460-6984.2012.00197.x.","journal-title":"Int J Lang Commun Disord"},{"key":"950_CR38","doi-asserted-by":"publisher","unstructured":"McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17:97\u2013114. https:\/\/doi.org\/10.1007\/s00455-001-0109-1.","DOI":"10.1007\/s00455-001-0109-1"},{"key":"950_CR39","doi-asserted-by":"publisher","unstructured":"Olthoff A, Carstens P-O, Zhang S, von Fintel E, Friede T, Lotz J, et al. Evaluation of dysphagia by novel real-time MRI. Neurology. 2016;87:2132\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000003337.","DOI":"10.1212\/WNL.0000000000003337"},{"key":"950_CR40","doi-asserted-by":"publisher","unstructured":"Patel DA, Sharda R, Hovis KL, Nichols EE, Sathe N, Penson DF, et al. Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation. Dis Esophagus. 2017;30:1\u201323. https:\/\/doi.org\/10.1093\/dote\/dow028.","DOI":"10.1093\/dote\/dow028"},{"key":"950_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00455-016-9775-x","volume":"32","author":"SE Langmore","year":"2017","unstructured":"Langmore SE. History of fiberoptic endoscopic evaluation of swallowing for evaluation and management of pharyngeal dysphagia: changes over the years. Dysphagia. 2017;32:27\u201338. https:\/\/doi.org\/10.1007\/s00455-016-9775-x.","journal-title":"Dysphagia."},{"key":"950_CR42","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1186\/s42466-019-0021-5","volume":"1","author":"R Dziewas","year":"2019","unstructured":"Dziewas R, dem Brinke M a, Birkmann U, Br\u00e4uer G, Busch K, Cerra F, et al. Safety and clinical impact of FEES \u2013 results of the FEES-registry. Neurol Res Pract. 2019;1:2756. https:\/\/doi.org\/10.1186\/s42466-019-0021-5.","journal-title":"Neurol Res Pract."},{"key":"950_CR43","doi-asserted-by":"publisher","first-page":"204062231882162","DOI":"10.1177\/2040622318821622","volume":"10","author":"N Audag","year":"2019","unstructured":"Audag N, Goubau C, Toussaint M, Reychler G. Screening and evaluation tools of dysphagia in adults with neuromuscular diseases: a systematic review. Ther Adv Chronic Dis. 2019;10:2040622318821622. https:\/\/doi.org\/10.1177\/2040622318821622.","journal-title":"Ther Adv Chronic Dis"},{"key":"950_CR44","volume-title":"Dysphagia: foundation, theory and practice","author":"JAY Cichero","year":"2006","unstructured":"Cichero JAY, Murdoch BE. Dysphagia: foundation, theory and practice. Chichester, West Sussex PO19 8SQ, England: John Wiley & Sons, Ltd; 2006."},{"key":"950_CR45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5056\/15009","volume":"21","author":"JS Ryu","year":"2015","unstructured":"Ryu JS, Park DH, Kang JY. Application and interpretation of high-resolution manometry for pharyngeal dysphagia. J Neurogastroenterol Motil. 2015;21:283\u20137. https:\/\/doi.org\/10.5056\/15009.","journal-title":"J Neurogastroenterol Motil"},{"key":"950_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/CCRep.S10200","volume":"6","author":"K-Y Murata","year":"2013","unstructured":"Murata K-Y, Kouda K, Tajima F, Kondo T. Balloon dilation in sporadic inclusion body myositis patients with dysphagia. Clin Med Insights Case Rep. 2013;6:1\u20137. https:\/\/doi.org\/10.4137\/CCRep.S10200.","journal-title":"Clin Med Insights Case Rep"},{"key":"950_CR47","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/PHM.0b013e31818a50e2","volume":"87","author":"TH Oh","year":"2008","unstructured":"Oh TH, Brumfield KA, Hoskin TL, Kasperbauer JL, Basford JR. Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome. Am J Phys Med Rehabil. 2008;87:883\u20139. https:\/\/doi.org\/10.1097\/PHM.0b013e31818a50e2.","journal-title":"Am J Phys Med Rehabil"},{"key":"950_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5535\/arm.2016.40.2.197","volume":"40","author":"YS Lee","year":"2016","unstructured":"Lee YS, Lee KE, Kang Y, Im Yi T, Kim JS. Usefulness of submental ultrasonographic evaluation for dysphagia patients. Ann Rehabil Med. 2016;40:197\u2013205. https:\/\/doi.org\/10.5535\/arm.2016.40.2.197.","journal-title":"Ann Rehabil Med"},{"key":"950_CR49","doi-asserted-by":"publisher","unstructured":"Miura Y, Nakagami G, Yabunaka K, Tohara H, Murayama R, Noguchi H, et al. Method for detection of aspiration based on B-mode video ultrasonography. Radiol Phys Technol. 2014;7:290\u20135. https:\/\/doi.org\/10.1007\/s12194-014-0264-3.","DOI":"10.1007\/s12194-014-0264-3"},{"key":"950_CR50","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.ultrasmedbio.2012.04.017","volume":"38","author":"M-Y Hsiao","year":"2012","unstructured":"Hsiao M-Y, Chang Y-C, Chen W-S, Chang H-Y, Wang T-G. Application of ultrasonography in assessing oropharyngeal dysphagia in stroke patients. Ultrasound Med Biol. 2012;38:1522\u20138. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2012.04.017.","journal-title":"Ultrasound Med Biol"},{"key":"950_CR51","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1212\/wnl.48.3.712","volume":"48","author":"MC Dalakas","year":"1997","unstructured":"Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology. 1997;48:712\u20136. https:\/\/doi.org\/10.1212\/wnl.48.3.712.","journal-title":"Neurology."},{"key":"950_CR52","doi-asserted-by":"publisher","unstructured":"Aydogdu I, Kiylioglu N, Tarlaci S, Tanriverdi Z, Alpaydin S, Acarer A, et al. Diagnostic value of \u201cdysphagia limit\u201d for neurogenic dysphagia: 17 years of experience in 1278 adults. Clin Neurophysiol. 2015;126:634\u201343. https:\/\/doi.org\/10.1016\/j.clinph.2014.06.035.","DOI":"10.1016\/j.clinph.2014.06.035"},{"key":"950_CR53","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00455-012-9429-6","volume":"28","author":"SK Archer","year":"2013","unstructured":"Archer SK, Garrod R, Hart N, Miller S. Dysphagia in Duchenne muscular dystrophy assessed objectively by surface electromyography. Dysphagia. 2013;28:188\u201398. https:\/\/doi.org\/10.1007\/s00455-012-9429-6.","journal-title":"Dysphagia."},{"key":"950_CR54","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/jnnp.65.6.848","volume":"65","author":"C Ertekin","year":"1998","unstructured":"Ertekin C, Y\u00fcceyar N, Aydogdu I. Clinical and electrophysiological evaluation of dysphagia in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1998;65:848\u201356. https:\/\/doi.org\/10.1136\/jnnp.65.6.848.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"950_CR55","doi-asserted-by":"publisher","unstructured":"Barsotti S, Puccini G, Tripoli A, Cardelli C, Minichilli F, Volterrani D, et al. Assessment of swallowing function with oro-pharyngeal-esophageal scintigraphy in patients with idiopathic inflammatory myopathies. Neurogastroenterol Motil. 2019;31:e13599. https:\/\/doi.org\/10.1111\/nmo.13599.","DOI":"10.1111\/nmo.13599"},{"key":"950_CR56","doi-asserted-by":"publisher","unstructured":"\u2022 Alexanderson H. Exercise in myositis. Curr Treatm Opt Rheumatol. 2018;4:289\u201398. https:\/\/doi.org\/10.1007\/s40674-018-0113-3. This review discusses the evidence for exercise as an important part of the treatment in patients with inflammatory myopathies.","DOI":"10.1007\/s40674-018-0113-3"},{"key":"950_CR57","doi-asserted-by":"publisher","unstructured":"Johnson LG, Collier KE, Edwards DJ, Philippe DL, Eastwood PR, Walters SE, et al. Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis. J Clin Neuromuscul Dis. 2009;10:178\u201384. https:\/\/doi.org\/10.1097\/CND.0b013e3181a23c86.","DOI":"10.1097\/CND.0b013e3181a23c86"},{"key":"950_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/16501970306110","volume":"35","author":"S Arnardottir","year":"2003","unstructured":"Arnardottir S, Alexanderson H, Lundberg IE, Borg K. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med. 2003;35:31\u20135. https:\/\/doi.org\/10.1080\/16501970306110.","journal-title":"J Rehabil Med"},{"key":"950_CR59","doi-asserted-by":"publisher","unstructured":"Malandraki GA, Kaufman A, Hind J, Ennis S, Gangnon R, Waclawik A, et al. The effects of lingual intervention in a patient with inclusion body myositis and Sj\u00f6gren\u2019s syndrome: a longitudinal case study. Arch Phys Med Rehabil. 2012;93:1469\u201375. https:\/\/doi.org\/10.1016\/j.apmr.2012.02.010.","DOI":"10.1016\/j.apmr.2012.02.010"},{"key":"950_CR60","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1288\/00005537-198704000-00014","volume":"97","author":"MS Mendelsohn","year":"1987","unstructured":"Mendelsohn MS, McConnel FM. Function in the pharyngoesophageal segment. Laryngoscope. 1987;97:483\u20139. https:\/\/doi.org\/10.1288\/00005537-198704000-00014.","journal-title":"Laryngoscope."},{"key":"950_CR61","doi-asserted-by":"publisher","first-page":"G450","DOI":"10.1152\/ajpgi.1991.260.3.G450","volume":"260","author":"PJ Kahrilas","year":"1991","unstructured":"Kahrilas PJ, Logemann JA, Krugler C, Flanagan E. Volitional augmentation of upper esophageal sphincter opening during swallowing. Am J Phys. 1991;260:G450\u20136. https:\/\/doi.org\/10.1152\/ajpgi.1991.260.3.G450.","journal-title":"Am J Phys"},{"key":"950_CR62","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/02841850600774043","volume":"47","author":"K Bod\u00e9n","year":"2006","unstructured":"Bod\u00e9n K, Hallgren A, Witt HH. Effects of three different swallow maneuvers analyzed by videomanometry. Acta Radiol. 2006;47:628\u201333. https:\/\/doi.org\/10.1080\/02841850600774043.","journal-title":"Acta Radiol"},{"key":"950_CR63","doi-asserted-by":"publisher","unstructured":"\u2022 Beck AM, Kjaersgaard A, Hansen T, Poulsen I. Systematic review and evidence based recommendations on texture modified foods and thickened liquids for adults (above 17 years) with oropharyngeal dysphagia - an updated clinical guideline. Clin Nutr. 2018;37:1980\u201391. https:\/\/doi.org\/10.1016\/j.clnu.2017.09.002. This review discusses the evidence for the use of thickened liquids and modified food in patients with dysphagia; clinical recommendations are made.","DOI":"10.1016\/j.clnu.2017.09.002"},{"key":"950_CR64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12877-018-0839-7","volume":"18","author":"ST O\u2019Keeffe","year":"2018","unstructured":"O\u2019Keeffe ST. Use of modified diets to prevent aspiration in oropharyngeal dysphagia: is current practice justified? BMC Geriatr. 2018;18:167. https:\/\/doi.org\/10.1186\/s12877-018-0839-7.","journal-title":"BMC Geriatr"},{"key":"950_CR65","unstructured":"Ogawa-Momohara M, Muro Y, Kono M, Akiyama M. Prognosis of dysphagia in dermatomyositis. Clin Exp Rheumatol. 2019;165."},{"key":"950_CR66","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10165-011-0534-4","volume":"22","author":"N Miyasaka","year":"2012","unstructured":"Miyasaka N, Hara M, Koike T, Saito E, Yamada M, Tanaka Y. Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial. Mod Rheumatol. 2012;22:382\u201393. https:\/\/doi.org\/10.1007\/s10165-011-0534-4.","journal-title":"Mod Rheumatol"},{"key":"950_CR67","unstructured":"Marie I, Hachulla E, Levesque H, Reumont G, Ducrotte P, Cailleux N, et al. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol. 1999;26:2706\u20139."},{"key":"950_CR68","doi-asserted-by":"publisher","unstructured":"Vacchi C, Sebastiani M, Manfredi, A. and Ferri, C. A case of refractory dysphagia in the context of polymyositis treated with subcutaneous immunoglobulin and review of the literature. Clin Med Rev Case Rep 2017. doi:https:\/\/doi.org\/10.23937\/2378-3656\/1410184.","DOI":"10.23937\/2378-3656\/1410184"},{"key":"950_CR69","doi-asserted-by":"publisher","first-page":"458231","DOI":"10.1155\/2014\/458231","volume":"2014","author":"P Cherin","year":"2014","unstructured":"Cherin P, Delain J-C, Crave J-C, Cartry O. High-dose subcutaneous immunoglobulins for the treatment of severe treatment-resistant polymyositis. Case Rep Rheumatol. 2014;2014:458231\u20134. https:\/\/doi.org\/10.1155\/2014\/458231.","journal-title":"Case Rep Rheumatol"},{"key":"950_CR70","doi-asserted-by":"publisher","unstructured":"Cherin P, Pelletier S, Teixeira A, Laforet P, Simon A, Herson S, et al. Intravenous immunoglobulin for dysphagia of inclusion body myositis. Neurology. 2002;58:326. https:\/\/doi.org\/10.1212\/wnl.58.2.326.","DOI":"10.1212\/wnl.58.2.326"},{"key":"950_CR71","unstructured":"Dobloug C, Walle-Hansen R, Gran JT, Molberg O. Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients. Clin Exp Rheumatol. 2012:838\u201342."},{"key":"950_CR72","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000441490","volume":"7","author":"P Cherin","year":"2015","unstructured":"Cherin P, Delain J-C, de Jaeger C, Crave J-C. Subcutaneous immunoglobulin use in inclusion body myositis: a review of 6 cases. Case Rep Neurol. 2015;7:227\u201332. https:\/\/doi.org\/10.1159\/000441490.","journal-title":"Case Rep Neurol"},{"key":"950_CR73","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/mus.23895","volume":"48","author":"K Pars","year":"2013","unstructured":"Pars K, Garde N, Skripuletz T, Pul R, Dengler R, Stangel M. Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia. Muscle Nerve. 2013;48:838\u20139. https:\/\/doi.org\/10.1002\/mus.23895.","journal-title":"Muscle Nerve"},{"key":"950_CR74","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/IJGM.S198031","volume":"12","author":"N Mohannak","year":"2019","unstructured":"Mohannak N, Pattison G, Hird K, Needham M. Dysphagia in patients with sporadic inclusion body myositis: management challenges. Int J Gen Med. 2019;12:465\u201374. https:\/\/doi.org\/10.2147\/IJGM.S198031.","journal-title":"Int J Gen Med"},{"key":"950_CR75","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00455-012-9402-4","volume":"27","author":"Z Dou","year":"2012","unstructured":"Dou Z, Zu Y, Wen H, Wan G, Jiang L, Hu Y. The effect of different catheter balloon dilatation modes on cricopharyngeal dysfunction in patients with dysphagia. Dysphagia. 2012;27:514\u201320. https:\/\/doi.org\/10.1007\/s00455-012-9402-4.","journal-title":"Dysphagia."},{"key":"950_CR76","doi-asserted-by":"crossref","unstructured":"Parres C. Pharyngoesophageal dilation and botulinum toxin therapy for dysphagia in patients with inclusion body myositis (P3.157). Neurology. 2015:P3.157.","DOI":"10.1212\/WNL.84.14_supplement.P3.157"},{"key":"950_CR77","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.anl.2009.04.007","volume":"36","author":"H Nagano","year":"2009","unstructured":"Nagano H, Yoshifuku K, Kurono Y. Polymyositis with dysphagia treated with endoscopic balloon dilatation. Auris Nasus Larynx. 2009;36:705\u20138. https:\/\/doi.org\/10.1016\/j.anl.2009.04.007.","journal-title":"Auris Nasus Larynx"},{"key":"950_CR78","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/000348949410300105","volume":"103","author":"I Schneider","year":"1994","unstructured":"Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum a toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol. 1994;103:31\u20135. https:\/\/doi.org\/10.1177\/000348949410300105.","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"950_CR79","doi-asserted-by":"publisher","unstructured":"Alfonsi E, Merlo IM, Ponzio M, Montomoli C, Tassorelli C, Biancardi C, et al. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment. J Neurol Neurosurg Psychiatry. 2010;81:54\u201360. https:\/\/doi.org\/10.1136\/jnnp.2009.174698.","DOI":"10.1136\/jnnp.2009.174698"},{"key":"950_CR80","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00455-007-9132-1","volume":"23","author":"E Krause","year":"2008","unstructured":"Krause E, Schirra J, G\u00fcrkov R. Botulinum toxin a treatment of cricopharyngeal dysphagia after subarachnoid hemorrhage. Dysphagia. 2008;23:406\u201310. https:\/\/doi.org\/10.1007\/s00455-007-9132-1.","journal-title":"Dysphagia."},{"key":"950_CR81","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.apmr.2006.06.018","volume":"87","author":"DY Kim","year":"2006","unstructured":"Kim DY, C-i P, Ohn SH, Moon JY, Chang WH, S-w P. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction. Arch Phys Med Rehabil. 2006;87:1346\u201351. https:\/\/doi.org\/10.1016\/j.apmr.2006.06.018.","journal-title":"Arch Phys Med Rehabil"},{"key":"950_CR82","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s10072-016-2586-x","volume":"37","author":"C Di Pede","year":"2016","unstructured":"Di Pede C, Masiero S, Bonsangue V, Ragona RM, Del Felice A. Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia. Neurol Sci. 2016;37:1743\u20135. https:\/\/doi.org\/10.1007\/s10072-016-2586-x.","journal-title":"Neurol Sci"},{"key":"950_CR83","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1155\/2004\/360537","volume":"18","author":"LWC Liu","year":"2004","unstructured":"Liu LWC, Tarnopolsky M, Armstrong D. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Can J Gastroenterol. 2004;18:397\u20139.","journal-title":"Can J Gastroenterol"},{"key":"950_CR84","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00455-001-0059-7","volume":"16","author":"JJ Haapaniemi","year":"2001","unstructured":"Haapaniemi JJ, Laurikainen EA, Pulkkinen J, Marttila RJ. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia. 2001;16:171\u20135. https:\/\/doi.org\/10.1007\/s00455-001-0059-7.","journal-title":"Dysphagia."},{"key":"950_CR85","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/000348941312200205","volume":"122","author":"EA Kelly","year":"2013","unstructured":"Kelly EA, Koszewski IJ, Jaradeh SS, Merati AL, Blumin JH, Bock JM. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction. Ann Otol Rhinol Laryngol. 2013;122:100\u20138. https:\/\/doi.org\/10.1177\/000348941312200205.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"950_CR86","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00455-001-0074-8","volume":"16","author":"GY Shaw","year":"2001","unstructured":"Shaw GY, Searl JP. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia. 2001;16:161\u20137. https:\/\/doi.org\/10.1007\/s00455-001-0074-8.","journal-title":"Dysphagia."},{"key":"950_CR87","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1017\/s031716710002953x","volume":"16","author":"MJ Danon","year":"1989","unstructured":"Danon MJ, Friedman M. Inclusion body myositis associated with progressive dysphagia: treatment with cricopharyngeal myotomy. Can J Neurol Sci. 1989;16:436\u20138. https:\/\/doi.org\/10.1017\/s031716710002953x.","journal-title":"Can J Neurol Sci"},{"key":"950_CR88","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/mus.880140514","volume":"14","author":"A Verma","year":"1991","unstructured":"Verma A, Bradley WG, Adesina AM, Sofferman R, Pendebury WW. Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia. Muscle Nerve. 1991;14:470\u20133.","journal-title":"Muscle Nerve"},{"key":"950_CR89","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780280606","volume":"28","author":"LJ Kagen","year":"1985","unstructured":"Kagen LJ, Hochman RB, Strong EW. Cricopharyngeal obstruction in inflammatory myopathy (polymyositis\/dermatomyositis). Report of three cases and review of the literature. Arthritis Rheum. 1985;28:630\u20136. https:\/\/doi.org\/10.1002\/art.1780280606.","journal-title":"Arthritis Rheum"},{"key":"950_CR90","doi-asserted-by":"publisher","first-page":"bcr2012008058","DOI":"10.1136\/bcr-2012-008058","volume":"2013","author":"A Sanei-Moghaddam","year":"2013","unstructured":"Sanei-Moghaddam A, Kumar S, Jani P, Brierley C. Cricopharyngeal myotomy for cricopharyngeus stricture in an inclusion body myositis patient with hiatus hernia: a learning experience. BMJ Case Rep. 2013;2013:bcr2012008058. https:\/\/doi.org\/10.1136\/bcr-2012-008058.","journal-title":"BMJ Case Rep"},{"key":"950_CR91","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1111\/j.1572-0241.1999.01507.x","volume":"94","author":"RB Williams","year":"1999","unstructured":"Williams RB, Ali GN, Hunt DR, Wallace KL, Cook IJ. Cricopharyngeal myotomy does not increase the risk of esophagopharyngeal acid regurgitation. Am J Gastroenterol. 1999;94:3448\u201354. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01507.x.","journal-title":"Am J Gastroenterol"},{"key":"950_CR92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0002-9343(99)00334-4","volume":"108","author":"JH Kelly","year":"2000","unstructured":"Kelly JH. Management of upper esophageal sphincter disorders: indications and complications of myotomy. Am J Med. 2000;108:43\u20136. https:\/\/doi.org\/10.1016\/s0002-9343(99)00334-4.","journal-title":"Am J Med"},{"key":"950_CR93","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.3748\/wjg.v20.i24.7739","volume":"20","author":"AA Rahnemai-Azar","year":"2014","unstructured":"Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20:7739\u201351. https:\/\/doi.org\/10.3748\/wjg.v20.i24.7739.","journal-title":"World J Gastroenterol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00950-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-020-00950-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00950-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T19:51:45Z","timestamp":1723492305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-020-00950-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":93,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-00950-3","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"28 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"JS has received payments for advisory boards, speaker\u2019s honoraria, travel expenses, or research projects from Alnylam, Bayer, Biogen, BioMarin, Biotest, CSL Behring, Grifols, Hormosan, LFB, Novartis, Octapharma, and Pfizer.RZ has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"74"}}